Company Filing History:
1 out of 4,770 
1 out of 832,880 Years Active: 2004-2006
Title: Neelima Bhat: Innovator in Nucleoside Derivatives
Introduction
Neelima Bhat is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleoside derivatives that serve as inhibitors of RNA-dependent RNA viral polymerase. With a total of 2 patents, his work is crucial in the fight against viral infections.
Latest Patents
Neelima Bhat's latest patents focus on nucleoside compounds that inhibit RNA-dependent RNA viral replication. The first patent describes these compounds as effective inhibitors of hepatitis C virus (HCV) NS5B polymerase. This invention provides pharmaceutical compositions containing these nucleoside compounds, which can be used alone or in combination with other agents to treat RNA-dependent RNA viral infections. The second patent reiterates the same findings, emphasizing the importance of these compounds in treating hepatitis C infection and inhibiting viral replication.
Career Highlights
Throughout his career, Neelima Bhat has worked with notable companies, including Merck & Company, Inc. His expertise in the pharmaceutical industry has allowed him to contribute to significant advancements in viral infection treatments.
Collaborations
Neelima has collaborated with various professionals in his field, including Balkrishen Bhat and Anne Bettina Eldrup. Their combined efforts have furthered research and development in the area of nucleoside derivatives.
Conclusion
Neelima Bhat's innovative work in nucleoside derivatives has positioned him as a key figure in the pharmaceutical industry. His patents are vital for developing treatments for RNA-dependent RNA viral infections, particularly hepatitis C.